No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

Published Date: 30 Sep 2024

Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Modified personalized cancer vaccine generates powerful immune response

2.

Is There a Role for Stimulants in Beating Cancer Fatigue?

3.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

4.

New research demonstrates a method for screening people at high risk for pancreatic cancer.

5.

According to JAMA, even four minutes a day of exercise can lower the risk of cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot